Related references
Note: Only part of the references are listed.The reactome pathway knowledgebase
Bijay Jassal et al.
NUCLEIC ACIDS RESEARCH (2020)
Effects of Cannabis Use on the Protein and Lipid Profile of Olfactory Neuroepithelium Cells from Schizophrenia Patients Studied by Synchrotron-Based FTIR Spectroscopy
Sergi Saladrigas-Manjon et al.
BIOMOLECULES (2020)
Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use
Daniel Guinart et al.
SCHIZOPHRENIA BULLETIN (2020)
Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
Ines Lbarra-Lecue et al.
FRONTIERS IN PHARMACOLOGY (2020)
Smelling the Dark Proteome: Functional Characterization of PITH Domain-Containing Protein 1 (C1orf128) in Olfactory Metabolism
Mercedes Lachen-Montes et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
Carolina Muguruza et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Adolescent exposure Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons
Michael L. Miller et al.
MOLECULAR PSYCHIATRY (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
Anastasiia S. Boiko et al.
HELIYON (2019)
The contribution of alternative splicing to genetic risk for psychiatric disorders
E. Reble et al.
GENES BRAIN AND BEHAVIOR (2018)
Seh1 targets GATOR2 and Nup153 to mitotic chromosomes
Melpomeni Platani et al.
JOURNAL OF CELL SCIENCE (2018)
Cannabis Users Show Enhanced Expression of CB1-5HT(2A) Receptor Heteromers in Olfactory Neuroepithelium Cells
Liliana Galindo et al.
MOLECULAR NEUROBIOLOGY (2018)
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Ines Ibarra-Lecue et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Arginase-II activates mTORC1 through myosin-1b in vascular cell senescence and apoptosis
Yi Yu et al.
CELL DEATH & DISEASE (2018)
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
Joelle A. Pasman et al.
NATURE NEUROSCIENCE (2018)
Cannabis consumption and psychosis or schizophrenia development
Maria Bettina Ortiz-Medina et al.
INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY (2018)
Psychiatric disorders biochemical pathways unraveled by human brain proteomics
Veronica M. Saia-Cereda et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Oxidative metabolism may be associated with negative symptoms in schizophrenia
Mehmet Gunes et al.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY (2017)
Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation
Karl Bertram et al.
CELL (2017)
Is there a role for immune-to-brain communication in schizophrenia?
Golam M. Khandaker et al.
PSYCHOPHARMACOLOGY (2016)
Astrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5-Nrf2 pathway
D. Jimenez-Blasco et al.
CELL DEATH AND DIFFERENTIATION (2015)
Reduced protein synthesis in schizophrenia patient-derived olfactory cells
J. A. English et al.
TRANSLATIONAL PSYCHIATRY (2015)
The proteome of schizophrenia
Juliana M. Nascimento et al.
NPJ SCHIZOPHRENIA (2015)
Neural stem cell- and neurogenesis-related gene expression profiles in the young and aged dentate gyrus
Geetha A. Shetty et al.
AGE (2013)
Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications
Alfredo Ramos-Miguel et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
A Combined Metabonomic and Proteomic Approach Identifies Frontal Cortex Changes in a Chronic Phencyclidine Rat Model in Relation to Human Schizophrenia Brain Pathology
Hendrik Wesseling et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Miquel Bioque et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
Marta Di Forti et al.
BIOLOGICAL PSYCHIATRY (2012)
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls
Julian A. J. Jaros et al.
JOURNAL OF PROTEOMICS (2012)
Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis
Ludovic C. Gillet et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
Concise Review: Patient-Derived Olfactory Stem Cells: New Models for Brain Diseases
Alan Mackay-Sim
STEM CELLS (2012)
Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3
Melanie Föcking et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases
G. Benitez-King et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Mutation of the Mitochondrial Tyrosyl-tRNA Synthetase Gene, YARS2, Causes Myopathy, Lactic Acidosis, and Sideroblastic Anemia-MLASA Syndrome
Lisa G. Riley et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia
Daniel Martins-de-Souza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses
S. Jayanthi et al.
MOLECULAR PSYCHIATRY (2010)
Mitochondrial Dysfunction and Psychiatric Disorders
Gislaine T. Rezin et al.
NEUROCHEMICAL RESEARCH (2009)
BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams
Tim Hulsen et al.
BMC GENOMICS (2008)
Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
Jim van Os et al.
SCHIZOPHRENIA BULLETIN (2008)
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues
J. T-J Huang et al.
MOLECULAR PSYCHIATRY (2008)
Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia
L. M. Camargo et al.
MOLECULAR PSYCHIATRY (2007)
Cannabinoids modulate the P-type high-voltage-activated calcium currents in Purkinje neurons
Alexander Fisyunov et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes
Clare L. Beasley et al.
PROTEOMICS (2006)
Altered levels of acute phase proteins in the plasma of patients with schizophrenia
Yifeng Yang et al.
ANALYTICAL CHEMISTRY (2006)
Myosin 1b modulates the morphology and the protein transport within multi-vesicular sorting endosomes
L Salas-Cortes et al.
JOURNAL OF CELL SCIENCE (2005)
Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A
A Nishi et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia
I Maurer et al.
SCHIZOPHRENIA RESEARCH (2001)
Share Paper
